<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<!-- Sitemap is generated on 2026-04-25 17:22:38 GMT -->
	<url>
		<loc>https://merlintrader.com/vistagen-therapeutics-april2026-dd/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-25T15:21:46+00:00</news:publication_date>
			<news:title>Vistagen Therapeutics (Nasdaq: $VTGN): Refisolone FDA Green Light, PALISADE-3 Failure and the High-Stakes PALISADE-4 Catalyst</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/vtgn1-e1777129938653.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/intellia-therapeutics-april2026-precatalyst-update/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-25T13:50:34+00:00</news:publication_date>
			<news:title>Intellia Therapeutics (Nasdaq: $NTLA): HAELO Turns Lonvo-z Into the Next Major In Vivo CRISPR Test</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/ntla27aprpng-e1777124759173.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/wall-street-weekly-recap-and-next-week-setup/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-25T09:50:50+00:00</news:publication_date>
			<news:title>Wall Street weekly recap and next-week setup april27-2026  ( $SPY )</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/weeklyapril25i-e1777110001572.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/aeye-inc-april2026-deep-dive/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-24T22:52:38+00:00</news:publication_date>
			<news:title>AEye Inc. (Nasdaq: $LIDR): Retail Momentum Meets the LiDAR Turnaround Story Ahead of Q1 Earnings</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/lidr-e1777070629435.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/onemednet-corporation-april2026-dd/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-24T17:07:10+00:00</news:publication_date>
			<news:title>OneMedNet Corporation (Nasdaq: $ONMD): Palantir, iRWD and the Micro-Cap Real-World Data Pivot</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/ONMD-April26-e1777050288978.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/oklo-nvidia-partnership-ai-power/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-24T12:55:23+00:00</news:publication_date>
			<news:title>Oklo Inc. (NYSE: $OKLO): Nvidia Partnership, AI Power Demand and Nuclear Deployment Outlook</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/oklo-e1777035236675.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/ses-ai-corporation-earnings-beat/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-24T09:55:23+00:00</news:publication_date>
			<news:title>SES AI Corporation (NYSE: $SES): Earnings Beat, Revenue Growth and 2026 Outlook</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/sesaprilbeat-e1777024752432.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/13055-2/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-24T09:20:47+00:00</news:publication_date>
			<news:title>Starfighters Space Deep Dive ( $FJET): FJET’s Space-Test Platform, C-STARS Catalyst, Blackstar Optionality, Insider Picture and Funding Risk</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/fjetaapril-e1777022400975.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://merlintrader.com/grace-therapeutics-crl-april23/</loc>
		<news:news>
			<news:publication>
				<news:name>Merlintrader Trading Pub</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-04-23T20:12:17+00:00</news:publication_date>
			<news:title>Grace Therapeutics ( $GRCE): the clinical thesis is still alive, but the FDA CRL resets the clock</news:title>
		</news:news>
		<image:image>
			<image:loc>https://merlintrader.com/wp-content/uploads/2026/04/grceapril23-e1776974548946.png</image:loc>
		</image:image>
	</url>
</urlset>
<!-- Sitemap is generated for this view -->
